#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodevelopmental disorder Meningococcal immunisation Malignant neoplasm of choroid Myeloid leukaemia Mantle cell lymphoma Frontotemporal dementia Metastatic gastric cancer Haemophilia A with anti factor VIII Chronic inflammatory demyelinating polyradiculoneuropathy Immunodeficiency congenital B-cell lymphoma refractory Von Hippel-Lindau disease Glomerulonephritis membranous Gastrointestinal cancer metastatic Homocystinuria More trials…

    Learn about Rare Diseases

    Usher’s syndrome Amyotrophic lateral sclerosis – Treatment Idiopathic pulmonary fibrosis – Life with Disease Breast angiosarcoma metastatic – Basic Information Waldenstrom’s macroglobulinaemia – Diagnostics Aicardi-Goutieres syndrome – Basic Information Alternating hemiplegia of childhood – Basic Information Small intestine leiomyosarcoma – Treatment Atypical haemolytic uraemic syndrome Progressive multifocal leukoencephalopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pralsetinib Vx-522 Cellulose, Microcrystalline TETRODOTOXIN Pelareorep Prednisone Pariglasgene Brecaparvovec Nintedanib XELAFASLATIDE SGN-ALPV Benzyl Alcohol Soya-Bean Oil Refined Diphenhydramine Ribitol GSKVX000000070248 Ibuprofen Arginine Aminocaproic Acid Melatonin Vitamin A Bp Trabectedin More therapies…

    Learn about Your Condition

    Intracranial calcification Pelvic venous thrombosis Uveal melanoma Renal impairment Cerebral amyloid angiopathy Femoral neck fracture Krabbe's disease Uterine leiomyosarcoma Plasmablastic lymphoma Uterine cancer Thermal burn Oxygen therapy Oropharyngeal cancer Colorectal cancer stage III Schizophrenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diffuse large B-cell lymphoma

  • Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Epcoritamab
    Germany

  • Study of dapagliflozin to prevent heart complications during lymphoma treatment in patients receiving first-line therapy

    Recruiting

    2 1 1
    Investigated Diseases:
    • T-cell lymphoma
    • Anaplastic large cell lymphoma T- and null-cell types
    • Follicular lymphoma
    Investigated Drugs:
    • Placebo
    Denmark

  • Study Comparing Zilovertamab Vedotin with Drug Combination for Untreated Patients with Diffuse Large B-Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Zilovertamab Vedotin
    • Polatuzumab Vedotin
    • Cyclophosphamide
    Belgium Germany Ireland Italy Poland

  • Study of Epcoritamab, Lenalidomide, and Rituximab for Patients with Relapsed and Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    • Central nervous system lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Lenalidomide
    • Rituximab
    France

  • Study of Zilovertamab Vedotin and Drug Combination for Untreated Diffuse Large B-Cell Lymphoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone Acetate
    • Zilovertamab Vedotin
    Belgium Denmark France Greece Hungary Italy +5

  • Study on the Safety and Effectiveness of AZD0486 Alone or with Other Drugs for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, or Large B-Cell Lymphoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Vinorelbine
    • Acalabrutinib
    • Betamethasone Sodium Phosphate
    Czechia Denmark France Germany Spain
1 2 3 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!